No image available for this title

LITERATURE

Coronary Stent Restenosis in Patients Treated With Cilostazol


Restenosis after implantation of coronary artery stents remains a significant clinical problem. We undertook
a randomized, double-blind, placebo-controlled trial to determine whether cilostazol, a drug that suppresses intimal
proliferation, would reduce renarrowing in patients after stent implantation in native coronary arteries


Availability

Antiplat-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Circulation 2005;112;2826-2832
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous